MDGA1 Gene Variants and Risk for Restless Legs Syndrome

Area of Science:

• Genetics
• Neuroscience
• Pharmacogenomics

Background:

• The MAM domain-containing glycosylphosphatidylinositol anchor 1 (MDGA1) gene is implicated in synaptic inhibition and identified as a potential restless legs syndrome (RLS) risk gene.
• Previous research in a Chinese population indicated elevated MDGA1 methylation in idiopathic RLS (iRLS) patients.

Purpose of the Study:

• To investigate the association between common MDGA1 gene variants and iRLS risk in a Caucasian Spanish population.
• To explore the influence of MDGA1 genotype frequencies on RLS onset, severity, family history, and treatment response.

Main Methods:

• Genotyping of three common MDGA1 single nucleotide variants (SNVs): rs10947690, rs61151079, and rs79792089.
• Analysis of genotype and allelic variant frequencies in 263 iRLS patients and 280 healthy controls using a TaqMan-based qPCR assay.
• Correlation analysis with clinical variables including age at onset, gender, family history, and drug response.

Main Results:

• No significant differences in genotype or allelic variant frequencies of the studied MDGA1 SNVs were observed between iRLS patients and controls.
• MDGA1 variant frequencies did not correlate with age at onset, RLS severity (IRLSSGRS), family history, or response to dopamine agonists, clonazepam, or gabaergic drugs.
• These findings were consistent across the entire cohort and when analyzing genders separately.

Conclusions:

• Common missense SNVs within the MDGA1 gene are not associated with the risk of developing idiopathic RLS in the Caucasian Spanish population.
• The investigated MDGA1 variants do not appear to be major genetic contributors to iRLS in this demographic group.